My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanara MedTech Inc. - Common Stock (NQ:SMTI)

31.52 +0.33 (+1.06%)
Streaming Delayed Price Updated: 3:24 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 36,937
Open 31.31
Bid (Size) 31.04 (2)
Ask (Size) 31.55 (2)
Prev. Close 31.19
Today's Range 30.77 - 31.71
52wk Range 23.53 - 39.08
Shares Outstanding 8,902,351
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sanara MedTech Inc (NASDAQ:SMTI) Reports Mixed Q2 2025 Results with Revenue Beat and Narrower Loss, Shares Surge 8.4%
Sanara MedTech (SMTI) Q2 2025 earnings show revenue beat estimates with 28% YoY growth, narrowed EPS loss, and 8.4% pre-market surge. Strategic review for Tissue Health Plus underway. 
Via Chartmill
Sanara MedTech Sales Jump 28 Percent
Via The Motley Fool

Performance

YTD
-4.8%
-4.8%
1 Month
-6.1%
-6.1%
3 Month
+8.1%
+8.1%
6 Month
+14.4%
+14.4%
1 Year
+6.5%
+6.5%

More News

Read More
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Where Sanara MedTech Stands With Analysts
Via Benzinga
Earnings Scheduled For March 25, 2025
Via Benzinga
Sanara MedTech's Earnings: A Preview
Via Benzinga
Earnings Scheduled For August 13, 2025
Via Benzinga
Earnings Outlook For Sanara MedTech
Via Benzinga
Earnings Scheduled For May 14, 2025
Via Benzinga
Sanara MedTech: Q1 Earnings Insights
Via Benzinga
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
From Biomimetic Innovations Ltd
Via GlobeNewswire
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 25, 2024
Via Benzinga
Earnings Outlook For Sanara MedTech
Via Benzinga
Earnings Scheduled For November 13, 2023
Via Benzinga
Earnings Scheduled For August 14, 2023
Via Benzinga
Earnings Scheduled For May 15, 2023
Via Benzinga
Sanara MedTech Inc. (NASDAQ: SMTI) Highlighted for Surprising Price Action
Via Investor Brand Network
Sanara MedTech to Participate in Two Upcoming Healthcare Conferences
From Sanara MedTech Inc.
Via GlobeNewswire
Sanara MedTech Inc. Announces Third Quarter 2022 Results
From Sanara MedTech Inc.
Via GlobeNewswire
Sanara MedTech and InfuSystem Announce Wound Therapy Partnership
From Sanara MedTech Inc.
Via GlobeNewswire
InfuSystem and Sanara MedTech Announce Wound Therapy Partnership
From InfuSystem Holdings, Inc.
Via Business Wire
Earnings Scheduled For November 14, 2022
Via Benzinga

Frequently Asked Questions

Is Sanara MedTech Inc. - Common Stock publicly traded?
Yes, Sanara MedTech Inc. - Common Stock is publicly traded.
What exchange does Sanara MedTech Inc. - Common Stock trade on?
Sanara MedTech Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sanara MedTech Inc. - Common Stock?
The ticker symbol for Sanara MedTech Inc. - Common Stock is SMTI on the Nasdaq Stock Market
What is the current price of Sanara MedTech Inc. - Common Stock?
The current price of Sanara MedTech Inc. - Common Stock is 31.52
When was Sanara MedTech Inc. - Common Stock last traded?
The last trade of Sanara MedTech Inc. - Common Stock was at 10/06/25 03:24 PM ET
What is the market capitalization of Sanara MedTech Inc. - Common Stock?
The market capitalization of Sanara MedTech Inc. - Common Stock is 280.60M
How many shares of Sanara MedTech Inc. - Common Stock are outstanding?
Sanara MedTech Inc. - Common Stock has 281M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.